Inspire Wellness@Home launches Health and Wellness Lab Tests DTC in partnership with 1health.io

Portrait of a joyous attractive lady injecting medicine into her upper arm with an insulin pen

1health partners with Inspire Wellness@Home to bring health and wellness tests, such as inflammation, sleep and stress to heart health and thyroid to the broader direct to consumer market.

The new partnership between 1health and Inspire Wellness@Home enables Inspire to sell its innovative new health and wellness tests into the $1 billion direct-to-consumer lab testing market, which is forecasted to grow to $8.8 billion by 2031 according to research group Transparency Marketing in its report “North America Direct-to-Consumer Laboratory Testing Market Insights, 2021-2031” published in Q1 2022.

Partnering with 1health provides the front-end and back-end platform and experience to go to market without having to build the infrastructure from the ground up and allows Inspire to focus on their primary mission of servicing their customers. The platform makes ordering convenient, affordable, and simple, and enables individuals to take control of their health and wellness decisions from the comfort of their home.

“Inspire Diagnostics is excited to launch Inspire Wellness@Home in partnership with 1health,” said Managing Partner of Inspire Diagnostics, John Kang. “By offering a variety of at-home test options, Inspire Wellness@Home opens the door to a proactive approach to better health and living your best life. Simple to use tests, shipped right to your door, and supported by our national network of state-of-the-art labs.” Kang added.

Inspire Wellness@Home understands the need to capitalize on the direct-to-consumer market as it grows at an estimated 22% CAGR. “We are delighted that they selected 1health platform to meet their needs in this growing market and beyond,” states 1health CEO Mehdi Maghsoodnia.

Covid testing drove rapid change where healthcare providers understood that “preventive healthcare” is much more cost effective than having to take steps to treat a disease. As a result, at-home and genetic testing became part of this paradigm shift – enabling consumers to want more involvement in their healthcare decisions.

The direct-to-consumer lab testing market is expected to grow 22% and exceed more than $8 billion by 2031, according to The Transparency Market Research Report.

To read the press release click HERE

To learn more about Inspire Wellness@Home go to their website at Inspire Wellness@Home (inspirewellnessathome.com)

Latest Posts

Why the Right PGx Launch Strategy Will Save You Money, Time, and Resources

The field of CGx and PGx has grown leaps and bounds in the last 30 years. While the road ahead may be full of promises...

Read More...

Share with Your Patients, Providers, and Peers on How PGx Improves Patient Outcome

As advancement in PGx testing gains wider traction, the strength of PGx testing for laboratories as a growth opportunity in 2023 and beyond cannot be...

Read More...

Dante Genomics launches advance genome testing in partnership with 1health.io

Dante Genomics uses the 1health.io platform to accelerates their go to market and expand availability in all 50 states using the 1health online prescription services

Read More...

Patients Choice Labs selects 1health to Launch Genetic Testing to Consumers

With 1health.io technology, Patients Choice Laboratories customers will be able to order tests online

Read More...

Advances in Pharmacogenomic Testing

According to Straits Research, the pharmacogenomics market is $5.7 billion dollars, and is expected to grow at a CAGR of 8.47% this decade

Read More...

Learn how 1health can power your growth.